The pharmaceutical industry has typically been slow to adopt new data collection technology when it comes to clinical development. And to some degree this is understandable when you are working in a highly regulated industry where patient safety is the highest priority. Why change a proven process?
However, over the past decade we have witnessed the industry’s almost total acceptance of electronic data capture (EDC) technology and the growing acceptance of electronic patient reported outcomes (ePRO) applications.
In this report, Primary Investigators and Site Coordinators provide their satisfaction with product attributes, such as human-machine interface, technical support, EDC page load speed, etc.
For Sponsors and CROs:
- Understand how to select a technology partner that enhances your relationships with sites
- Identify and avoid study types users believe are least suited for the technologies
- Anticipate future adoption estimates for ePRO technologies
- Learn which technology providers have the best and worst integration capabilities with other technologies
For Technology Providers:
- Understand your own brand’s strength vs. competing providers Technology users’ brand preferences
- Receive detailed performance profiles for many major technology providers across critical success factors
- Identify competitive strengths and weaknesses and product satisfaction profiles across all major brands
- Technology users’ brand preferences
- High-level takeaways and implications: In this section we lay out what the data in this report is telling us and how it could impact your development strategies and operations. The goal of this section is to arm you with usable recommendations that can impact your current and future operations.
- EDC service provider section: This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Data Capture. These include adoption and preference for EDC as well as service provider brand leadership and performance.
- ePRO service provider section: This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Patient Reported Outcomes. These include
- adoption and preference for ePRO as well as service provider brand leadership and performance
- Trends and ideas impacting clinical development: In the end a sponsor or service provider wants to lock patient data on-time. This section ties together respondents’ views of how these technologies can and could improve the speed of and general conduct of clinical development studies.
ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive
- Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
- Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries. We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
- Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.
For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.